In its 2025 High-Cost Claims and Injectable Drug Trend Analysis, Sun Life highlights a familiar but costly trend: malignant neoplasm (cancer) and cardiovascular disease continue to rank among the top drivers of stop-loss claim reimbursements. These chronic conditions have consistently placed at or near the top of the list for years, underscoring how early detection can make a major difference in both cost and outcomes.
The best way to manage these high-cost claims isn’t to wait for them – it’s to find them early. That’s where MedBen WellLiving brings real value. Our wellness program is designed to catch chronic diseases like cancer and heart disease in their earliest, most treatable stages. In 2024, WellLiving clients spent 8.4% less on claims than non-WellLiving groups – a clear indication that early detection works.
Sun Life’s report also notes that million-dollar claims are growing steadily, up 6% over the past year and a full 56% since 2020. These large claims now represent a growing share of overall plan costs, with no sign of slowing.
For employers, these trends emphasize the importance of early intervention through routine wellness exams and screenings. MedBen WellLiving helps your plan members take action before high-risk conditions escalate into high-cost claims – protecting both health and your bottom line.
To learn how WellLiving can strengthen your wellness strategy, call your broker or contact MedBen Marketing.